Zobrazeno 1 - 10
of 53
pro vyhledávání: '"H Schwende"'
Autor:
R Gabdoulline, W Kaisers, A Gaspar, K Meganathan, M X Doss, S Jagtap, J Hescheler, A Sachinidis, H Schwender
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140803 (2015)
We performed a systematic analysis of gene expression features in early (10-21 days) development of human vs mouse embryonic cells (hESCs vs mESCs). Many development features were found to be conserved, and a majority of differentially regulated gene
Externí odkaz:
https://doaj.org/article/8fe5ba5ecc824c128de4491049b5d49d
Autor:
I Taha, J Gomme, S Suminska, H Schwende, D Butylin, J Doherty, A Beckmeyer-Borowko, G Farries
Publikováno v:
European Heart Journal. 43
Introduction Effective use of pharmacological therapy in de novo heart failure (HF) patients is key for slowing down the progression of HF. Randomised clinical trials have shown sacubitril/valsartan (sac/val), providing superior benefit over renin an
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Domingo A. Pascual-Figal, H Schwende, A.C. Pouleur, Candida Fonseca, W Bao, Yuksel Cavusoglu, Eva Lonn, Jan Belohlavek, Adele Noe, Ewa Straburzyńska-Migaj, Michele Senni, R Wachter, K K Witte, D Butylin, E Goncalvesova
Publikováno v:
European Heart Journal. 40
Background Optimisation of chronic heart failure (HF) therapy remains the key strategy to improve outcomes after hospitalisation for acute decompensated HF (ADHF) with reduced ejection fraction (HFrEF). Initiation and uptitration of disease-modifying
Autor:
Adele Noe, J Behlolavek, Margaret F. Prescott, W Bao, Domingo A. Pascual-Figal, H Schwende, Michele Senni, A Chakrabarti, D Butylin, R Wachter
Publikováno v:
European Heart Journal. 40
Background NT-proBNP has diagnostic and prognostic value in patients with heart failure (HF). Compared with enalapril, sacubitril/valsartan (S/V) significantly reduced NT-proBNP within 1 week (wk) of administration and reduced HF re-hospitalisation i
Autor:
W Bao, Arhit Chakrabarti, Ewa Straburzyńska-Migaj, Transition Investigators, Candida Fonseca, Michele Senni, Klaus K. Witte, Adele Noe, Rolf Wachter, Domingo A. Pascual-Figal, H Schwende, Jan Belohlavek, D Butylin, Christian Mueller, Eva Lonn
Publikováno v:
European journal of heart failureReferences. 22(2)
Aims: Sacubitril/valsartan has shown efficacy and tolerability in patients with heart failure (HF) and reduced ejection fraction (HFrEF) in the ambulatory setting (PARADIGM-HF), and following stabilisation of acutely decompensated HF (ADHF) (PIONEER-
Autor:
Jan Belohlavek, R Wachter, Domingo A. Pascual-Figal, Candida Fonseca, H Schwende, Adele Noe, Zhanna Kobalava, Klaus K. Witte, E Strabuzynska-Migaj, Michele Senni, D Butylin
Publikováno v:
European Heart Journal. 39
Autor:
Christian Mueller, W Bao, K K Witte, Domingo A. Pascual-Figal, D Butylin, H Schwende, Ewa Straburzyńska-Migaj, S. Michele, R Wachter, Adele Noe, Eva Lonn, Jan Belohlavek, Candida Fonseca
Publikováno v:
Heart, Lung and Circulation. 28:S177-S178
Autor:
Jan Belohlavek, Domingo A. Pascual-Figal, H Schwende, S. Michele, Christian Mueller, W Bao, Ewa Straburzyńska-Migaj, K K Witte, D Butylin, Adele Noe, R Wachter, Candida Fonseca, Eva Lonn
Publikováno v:
Heart, Lung and Circulation. 28:S178
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.